Innoviva Inc (INVA) concluded trading on Thursday at a closing price of $17.39, with 3.27 million shares of worth about $56.95 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.73% during that period and on March 13, 2025 the price saw a loss of about -0.11%. Currently the company’s common shares owned by public are about 62.66M shares, out of which, 62.01M shares are available for trading.
Stock saw a price change of -1.14% in past 5 days and over the past one month there was a price change of -3.71%. Year-to-date (YTD), INVA shares are showing a performance of 0.23% which increased to 17.58% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $14.32 but also hit the highest price of $21.28 during that period. The average intraday trading volume for Innoviva Inc shares is 662.83K. The stock is currently trading -2.33% below its 20-day simple moving average (SMA20), while that difference is down -3.39% for SMA50 and it goes to -4.89% lower than SMA200.
Innoviva Inc (NASDAQ: INVA) currently have 62.66M outstanding shares and institutions hold larger chunk of about 111.25% of that.
The stock has a current market capitalization of $1.09B and its 3Y-monthly beta is at 0.51. PE ratio of stock for trailing 12 months is 83.13, while it has posted earnings per share of $0.21 in the same period. Its PEG reads 1.17 and has Quick Ratio of 2.21 while making debt-to-equity ratio of 0.65. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INVA, volatility over the week remained 2.21% while standing at 2.14% over the month.
Stock’s fiscal year EPS is expected to rise by 329.85% while it is estimated to increase by 12.21% in next year. EPS is likely to grow at an annualized rate of 70.95% for next 5-years, compared to annual growth of -24.00% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Scotiabank on March 07, 2025 offering a Sector outperform rating for the stock and assigned a target price of $55 to it. On July 20, 2022, Goldman Initiated their recommendations, while on November 20, 2017, Deutsche Bank Initiated their ratings for the stock with a price target of $13.
